Introduction {#s1}
============

Neuronal hyperexcitability following the cessation of chronic alcohol intake (i.e. alcohol withdrawal) often increases susceptibility to generalized tonic-clonic seizures. The inferior colliculus (IC) plays a central role in auditory information processing. In rodents, the IC is critically involved in the initiation of acoustically-evoked reflex seizures (i.e. audiogenic seizures, or AGSs) during alcohol withdrawal ([@CIT0011]; [@CIT0004]; [@CIT0022], [@CIT0023]; [@CIT0008]; [@CIT0002]). Electrophysiology studies revealed increased firing of IC neurons both prior to and during AGSs in rats subjected to alcohol withdrawal ([@CIT0008]; [@CIT0002]). Similarly, *in vitro* studies revealed elevated excitability of IC neurons following alcohol withdrawal ([@CIT0027]; [@CIT0005]; [@CIT0005]). These functional findings support the importance of IC neurons in the networks that underlie alcohol withdrawal--induced seizures (AWSs; [@CIT0002]).

Voltage-gated Ca^2+^ (Ca~V~) channels play an important role in the mechanisms that underlie the neuronal hyperexcitability that leads to AWSs ([@CIT0037]). For example, blocking L-type Ca~V~ channels (i.e. the Ca~V~1 family of Ca^2+^ channels) suppressed AGSs in rats subjected to alcohol withdrawal ([@CIT0019]). These findings suggest that remodeling of Ca~V~1 channels---at least in the IC---is a key factor associated with AGS initiation during alcohol withdrawal. Consistent with this hypothesis, we found that the current density of Ca~V~1 channels was elevated in IC neurons of rats subjected to alcohol withdrawal, and this increased current was associated with enhanced seizure susceptibility ([@CIT0025]).

In the mammalian brain, Ca~V~1 channels are comprised of two main isoforms, Ca~V~1.3 and Ca~V~1.2 channels; however, which isoform accounts for the increased current density in IC neurons during alcohol withdrawal is currently unknown. We previously reported that the increase in current density through Ca~V~1 channels observed 24 hours after alcohol withdrawal (i.e. when AWS susceptibility peaks) follows a parallel time course with the occurrence of seizure susceptibility; moreover, by 48 hours after withdrawal (when the animal is no longer susceptible to AWS), Ca~V~1 currents return to control levels ([@CIT0025]). A temporal study of the onset of AGS found that seizure susceptibility is absent prior to the 7^th^ hour of alcohol withdrawal, but progressively increases thereafter; thus, susceptibility peaks at 24 hours and is absent again at 48 hours ([@CIT0007]). Because alcohol withdrawal preferentially affects Ca~V~1 channels, we examined whether the expression of Ca~V~1.3 and/or Ca~V~1.2 L-type channels is altered in IC neurons following alcohol withdrawal and whether these increases are correlated with the onset of AWS susceptibility.

Methods {#s2}
=======

Animals {#s3}
-------

Male Sprague-Dawley rats (250--300g; Taconic) were used for these experiments. The animals were maintained in a temperature- and humidity-controlled room on a 12hr light/dark cycle with food and water available *ad libitum*. All efforts were made to minimize the number of animals used in these experiments. All experimental procedures were approved by the Georgetown University Animal Care and Use Committee and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Ethanol Administration {#s4}
----------------------

Ethanol (from a 95% stock solution) was administered by intragastric intubation in a 30% (v/v) solution in ISOMIL Infant Formula Concentrate (the ISOMIL formula was diluted 1:1 with water). Ethanol was administered as three daily doses delivered every 8 hours for 4 days, and the level of intoxication was evaluated using a standard behavior rating scale ([@CIT0028]; [@CIT0007]). The first dose of ethanol was 5g/kg body weight, and subsequent doses were adjusted for each animal in order to achieve a moderate (i.e. accentuated staggering gait and considerable elevation of the pelvis) but not severe (i.e. lethargy without pelvic or abdominal elevation) degree of ataxia ([@CIT0007]); the amount of ethanol administered daily ranged from 9 to 15g/kg. On the fourth day, ethanol treatment was terminated after the second dose. The behavioral signs of ethanol withdrawal include hyperactivity, tremors, tail spasticity, spontaneous seizures (myoclonus and forelimb clonic seizures), and acoustically-evoked startle response and seizures ([@CIT0028]; [@CIT0007]). The control-treated animals were maintained under similar conditions but were given the ISOMIL formula without ethanol. Weight loss and mortality were negligible in both the ethanol-treated and control-treated groups.

Seizure Testing {#s5}
---------------

To determine susceptibility to develop AGS, two animals from each group were randomly selected and tested for seizures 2--4 hours (the 3-hour group), 22--24 hours (the 24-hour group), and 46--48 hours (the 48-hour group) after ethanol withdrawal. The acoustic stimulus consisted of 100--110 decibel sound pressure level pure tones (Med Associates) or mixed sounds (delivered via an electrical bell) that were presented until seizure was elicited (or for 60sec if no seizure activity was observed), as described previously ([@CIT0032]). Animals that did not exhibit a seizure during the first trial were tested again two hours later. The animals used in the molecular studies were not subjected to acoustically-evoked seizure testing because evoked seizures can induce a long-lasting increase in extracellular GABA levels ([@CIT0034]), which in turn can alter the expression of Ca~V~1 channels. In addition, using animals that were not exposed to stimulus-induced seizures prevented the effects of seizure severity and/or duration on the expression of Ca~V~1 channels.

Blood Ethanol Levels {#s6}
--------------------

In a separate set of experiments, blood ethanol concentration (BEC) was measured in the control group and in the ethanol-treated group 3, 24, and 48 hours during ethanol withdrawal. The rats were anesthetized (50mg/kg Nembutal; i.p.), and blood was extracted by intracardiac sampling using a 21-gauge needle. Serum ethanol concentration was measured using an Analox model GM7 analyzer (Analox Instruments).

Western Blot Analysis {#s7}
---------------------

At 3, 24, and 48 hours during ethanol withdrawal, the animals were deeply anesthetized with pentobarbital (100mg/kg; i.p.), and the colliculi were immediately dissected and stored at --80°C until use. Tissue homogenates from each animal were lysed in 50mM Tris-HCl (pH 7.4), 300mM NaCl, 1% octylphenoxypolyethoxyethanol (Sigma-Aldrich), 10% glycerol, 1mM ethylenediaminetetracetic acid, and 1mM Na~3~VO~4~. The homogenates were cleared by centrifugation (13 800 x *g*, 4°C, 30min). The supernatants were transferred to sterile microtubes and stored at -80°C until use. Protein concentration in the supernatants was measured using the bicinchoninic acid assay and a Bio-Rad Model 680 spectrophotometer. For each sample, 60 μg of total protein was separated by electrophoresis in a 7.5% sodium dodecyl sulfate-polyacrylamide gel and electro-transferred to a nitrocellulose membrane (Bio-Rad). The membranes were blocked in Odyssey blocking buffer (LI-COR Biosciences) for one hour and then probed overnight at 4°C with primary rabbit antibodies against either the α1D subunit (CaV1.3-α1; 1:200; Alomone Labs) or the α1C subunit (CaV1.2-α1; 1:200; Alomone Labs). The membranes were also incubated with anti-glyceraldehyde 3-phosphate dehydrogenase antibody (1:10 000; Thermo Fisher Scientific) overnight at 4°C as an internal control. The membranes were probed with goat anti-mouse IRDye800 (1:10 000; LI-COR Biosciences) and goat anti-rabbit IR-Dye680 (1:10 000; LI-COR Biosciences) for 1 hour at room temperature, then scanned using an Odyssey Fc imager (LI-COR Biosciences).

RNA Isolation and Quantitative Real-Time PCR {#s8}
--------------------------------------------

To quantify the mRNA levels of the Ca~V~1.3 and Ca~V~1.2 α1 subunits in the IC, rats were subjected to the 4-day ethanol intoxication paradigm (or control treatment), then anesthetized 3, 24, and 48 hours after ethanol withdrawal. The brains were removed, and the IC was immediately dissected and stored at -80°C until use. Total RNA was extracted from the IC using the RNeasy lipid tissue mini kit in accordance with the manufacturer's instructions (Qiagen). RNA concentration was measured using an Eppendorf Biophotometer, and the samples were stored at -20°C. Complementary DNA was synthesized from 1 μg total RNA by reverse transcription using the Quantitect reverse transcription kit (Qiagen) and stored at -20°C. For each gene of interest, real-time polymerase chain reactions (PCRs) were performed in duplicate using the TaqMan fast universal PCR master kit (Applied Biosystems) in a StepOnePlus real-time PCR machine system (Applied Biosystems). The specific primers were as follows: CaV1.3 α1 subunit (rat *Cacna1d*); Rn.PT.49a.11686797.g, GenBank accession no. NM_017298 and CaV1.2 α1 subunit (rat *Cacna1c*); and Rn.PT.49a.9591539.g, GenBank accession no. NM_012517 (Integrated DNA Technologies). The amplification efficiencies of *Cacna1d* and *Cacna1c* were determined relative to a *β-actin* internal control using cycle conditions of denaturation at 95°C for 12sec followed by 40 cycles of 95°C for 1sec and 60°C for 12sec. After amplification, a crossing threshold (C~T~) value (representing the number of cycles required to reach a specific level of fluorescence) was determined for each sample.

Data Analysis {#s9}
-------------

The protein levels of the Ca~V~1.3 α1 and Ca~V~1.2 subunits were measured using densitometry of the corresponding bands (Odyssey Image Studio v3.2 software, LI-COR Biosciences). The integrated intensity of each band was normalized to the intensity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The mean of the control values was calculated, and the normalized intensity value of each control and alcohol-treated sample was expressed as a ratio relative to the mean control value. Fold change in mRNA expression was calculated using StepOne software with the equation 2^-∆∆C^ ~T~, where ∆∆C~T~ is the relative change of a given mRNA ([@CIT0020]). To obtain the 2^-∆∆C^ ~T~ value for each sample, the C~T~ value for *Cacna1c* and *Cacna1d* mRNA was first normalized to *β-actin*, and the resulting ∆C~T~ was calculated as follows: \[∆C~T~ ^*Cacna1d*^ = C~T~ ^*Cacna1d*^ - C~T~ ^*β-actin*^\] for *Cacna1d* (Ca~V~1.3) and \[∆C~T~ ^*Cacna1c*^ = C~T~ ^*Cacna1c*^ - C~T~ ^*β-actin*^\] for *Cacna1c* (Ca~V~1.2). Changes in *Cacna1d and Cacna1c* and mRNA during alcohol withdrawal were calculated relative to the control group using the following equation: \[∆∆C~T~ ^*Cacna1d*^ = (C~T~ ^*Cacna1d*^ - C~T~ ^*β-actin*^)~ethanol\ withdrawal~ -- (C~T~ ^*Cacna1d*^ - C~T~ ^*β-actin*^)~control\ group~\] or \[∆∆C~T~ ^*Cacna1c*^ = (C~T~ ^*Cacna1c*^ - C~T~ ^*β-actin*^)~ethanol\ withdrawal~ -- (C~T~ ^*Cacna1c*^ - C~T~ ^*β-actin*^)~control\ group~\]. The final mRNA levels were determined by calculating 2^-∆∆CT^. The prevalence of each type of seizure was analyzed using the chi-square (χ^2^) test. To evaluate differences in the protein and mRNA levels, one-way analyses of variance (ANOVA; *F*) followed by a Bonferroni or Student-Newman-keuls post hoc test were performed. Differences were considered significant at *p* \< 0.05, and the summary data are presented as the mean ± standard error of the mean or as a percentage (for the prevalence of wild running seizures \[WRSs\] and tonic-clonic seizures \[clonus\]).

Results {#s10}
=======

Ethanol Withdrawal Enhances the Susceptibility to Seizures {#s11}
----------------------------------------------------------

[Figure 1](#F1){ref-type="fig"} summarizes the susceptibility of each group to develop AGSs following control treatment or at 3, 24, and 48 hours during ethanol withdrawal. AGSs consisted of jumping and/or WRSs, which occasionally evolved into bouncing generalized clonus; 24 hours after ethanol withdrawal, these seizure types were observed in 100% (χ^2^ = 196, *p* \< 0.001 vs. control) and 60% (χ^2^ = 83, *p* \< 0.001 vs. control) of ethanol-treated rats, respectively. This susceptibility to AGS was transient, as these seizures were observed only in the 24-hour group, and not in the 3-hour or 48-hour group ([Figure 1](#F1){ref-type="fig"}). No seizures were observed in the control group. ANOVA revealed that the BEC group means were significantly different (*F* = 40, *p* \< 0.001). The BECs were significantly (t = 9, *p* \< 0.05) elevated in the 3-hour group (0.26±0.04g/dL, n = 4) compared with those of the 24 (0.01±0.001g/dL, n = 4) and 48 (0.01±0.001g/dL, n = 4) hour ethanol groups and the control group (0.005±0.001g/dL, n = 4).

![Prevalence of acoustically-evoked generalized seizures following ethanol withdrawal. These seizures consisted of wild running seizures (WRSs) or bouncing generalized tonic-clonic seizures (clonus \[C\]). At 24 hours after ethanol withdrawal, 100% and 60% of animals (n = 10) exhibited WRSs and clonus, respectively. No seizures were observed at 3 (n = 6) or 48 hours (n = 6) following ethanol withdrawal, and no seizures also were observed in the control group (n = 6, \**p* \< 0.001 versus control; chi-square test).](ijnppy_pyu123_f0001){#F1}

Ethanol Withdrawal Upregulates Ca~V~1 Channels at the mRNA Level {#s12}
----------------------------------------------------------------

[Figure 2](#F2){ref-type="fig"} summarizes the mRNA levels of the Ca~V~1.3 ([Figure 2A](#F2){ref-type="fig"}) and Ca~V~1.2 ([Figure 2B](#F2){ref-type="fig"}) α1 subunits (*Cacna1c* and *Cacna1d* mRNA, respectively) in IC tissues obtained from the control and ethanol-treated groups. The expression of both *Cacna1d* (*F* = 8, *p* \< 0.001) and *Cacna1c* (*F* = 6, *p* \< 0.01) mRNA were increased significantly in the IC following ethanol withdrawal. Interestingly, the expression of *Cacna1d* mRNA was significantly increased at the 24-hour time point (2^-∆∆CT^ = 1.9±0.2, n = 6, t = 4, *P* \< 0.05), but not at the 3-hour time points (2^-∆∆CT^ = 1.4±0.1, n = 6)- or 48 (2^-∆∆CT^ = 1.3±0.2, n = 6) during ethanol withdrawal, in comparison to the the control group (2^-∆∆CT^ = 1.0±0.1, n = 6; [Figure 2A](#F2){ref-type="fig"}). The level of Cacna1d mRNA was also significantly increased 24 hours during ethanol withdrawal compared to the 3-hour (t = 3, *p* \< 0.05) and 48-hour (t = 4, *p* \< 0.05) groups.

![Ethanol withdrawal upregulates *Cacna1d* and *Cacna1c* mRNA expression in the inferior colliculus (IC). The levels of *Cacna1d* (Ca~V~1.3 α1 subunit; panel A) and *Cacna1c* (Ca~V~1.2 α1 subunit; panel B) mRNA were measured in the IC; the data are expressed as the fold change relative to the control group. (A) The level of *Cacna1d* mRNA was significantly higher in the IC 24 hours after alcohol withdrawal compared to the control group and the other alcohol-treated groups. (B) The level of *Cacna1c* Ca~V~1.2 mRNA was significantly higher in the IC 24 and 48 hours after alcohol withdrawal compared to the control group. The level of *Cacna1c* Ca~V~1.2 mRNA also was significantly elevated 24 hours after alcohol withdrawal compared to the 3-hour group. The data are shown as mean ± standard error of the mean. n = 6 rats per group. \**p* \< 0.05 versus control (ANOVA followed by a Bonferroni test or Student-Newman-Keuls).](ijnppy_pyu123_f0002){#F2}

The expression of *Cacna1c* mRNA was significantly (t = 4, *p* \< 0.05) increased 24 hours (2^-∆∆CT^ = 1.5±0.1, n = 6) and 48 (2^-∆∆CT^ = 1.4±0.1, n = 6) during ethanol withdrawal compared to the control group (2^-∆∆CT^ = 1.0±0.1, n = 6, [Figure 2B](#F2){ref-type="fig"}). The expression of *Cacna1c* mRNA also was significantly increased in the 24-hour group compared to the 3-hour group during ethanol withdrawal (2^-∆∆CT^ = 1.1±0.1, n = 6, t = 3, *p* \< 0.05). No change in the *Cacna1c* mRNA expression was observed 3 hours during ethanol withdrawal compared with the control group ([Figure 2B](#F2){ref-type="fig"}). During ethanol withdrawal, the ratios of the mRNA expression levels of the *Cacna1d* to those of *Cacna1c* were 1.4:1.1, 1.9:1.5, and 1.3:1.4 at 3, 24, and 48 hours, respectively. Thus, a dominant expression of *Cacna1d* mRNA occurred at 3 and 24 hours following ethanol withdrawal.

Ethanol Withdrawal Upregulates Ca~V~1 Channels at the Protein Level {#s13}
-------------------------------------------------------------------

We next examined whether the increased expression of Ca~V~1 channels was reflected in a change in protein levels. [Figure 3](#F3){ref-type="fig"} summarizes the protein levels of Ca~V~1.3 ([Figure 3A](#F3){ref-type="fig"}) and Ca~V~1.2 ([Figure 3B](#F3){ref-type="fig"}) α1 subunits. Ethanol withdrawal significantly increased the protein levels of the Ca~V~1.3 (*F* = 7, *p* \< 0.001) but not of Ca~V~1.2 α1 subunit in the IC. Consistent with the *Cacna1d* mRNA levels, the protein level of Ca~V~1.3 α1 subunits was increased significantly 24 hours (152±8%, n = 8, t = 4, *p* \< 0.05) after ethanol withdrawal, but not at the earlier (3-hour group: 102±10%, n = 8) or later (48-hour group: 116±12%, n = 8) time points compared to the control group (100±8%, n = 8, [Figure 3A](#F3){ref-type="fig"}). Comparison between ethanol-treated groups reaveled that the protein expression level for the Ca~V~1.3-α1 subunit was significantly elevated in the 24-hour group compared to the 3-hour (t = 4, *p* \< 0.05) and 48-hour (t = 3, *p* \< 0.05) groups during the withdrawal.

![Ethanol withdrawal increases the protein levels of Ca~V~1.3 α1 subunits in the inferior colliculus (IC). Shown in insets are representative immunoblots of the (A\<B) GAPDH, (A) Ca~V~1.3 and (B) Ca~V~1.2 α1 subunits measured from control IC samples and IC samples obtained at the indicated times after ethanol withdrawal. The bar graphs summarize the relative protein levels of Ca~V~1.3 α1 and Ca~V~1.2 subunits in the IC, expressed as a percentage of the control group. The density of the 260kDa immunoreactive band (i.e. the Ca~V~1.3 α1 subunit; panel A) increased significantly in the IC 24 hours after ethanol withdrawal. The density of the 210kDa immunoreactive bands (i.e. the Ca~V~1.2 α1 subunit; panel B) did not change significantly following ethanol withdrawal. The summary data are shown as the mean ± standard error of the mean. n = 8 rats per group. \**p* \< 0.05 versus control (ANOVA followed by a Bonferroni test or Student-Newman-Keuls).](ijnppy_pyu123_f0003){#F3}

In contrast, the protein expression levels of the Ca~V~1.2-α1 subunit were increased by 6% at 3 hours (106±19%, n = 8) and 32% at 24 hours (132±16%, n = 8) during ethanol withdrawal, and then returned to control levels (100±19%, n = 8) at 48 hours (100±10, n = 8, [Figure 3B](#F3){ref-type="fig"}) later. The protein expression ratios of the Ca~V~1.3-α1 and Ca~V~1.2-α1 subunits were 100:106, 152:132, and 116:100 at 3, 24, and 48h during ethanol withdrawal, respectively. Thus, ethanol withdrawal favored the protein expression of Ca~V~1.3-α1 subunit at 24 hours during ethanol withdrawal when the susceptibility to seizures peaked.

Discussion {#s14}
==========

Here, we report that the mRNA and protein levels of the Ca~V~1.3 and Ca~V~1.2 α1 subunits increase in the IC during alcohol withdrawal, a condition that is associated with increased seizure susceptibility. In particular, expression of the Ca~V~1.3 α1 subunit was significantly increased 24 hours after alcohol withdrawal, when seizure susceptibility peaked. In contrast, expression of the Ca~V~1.2 α1 subunit increased 24 and 48 hours after alcohol withdrawal, when seizure susceptibility peaked and then resolved, respectively. Thus, expression of the Ca~V~1.3 α1 subunit changed in parallel with the occurrence of AWS, whereas upregulation of the Ca~V~1.2 1 subunit outlasted the period of AWS susceptibility. At the protein level, Western blot analyses revealed that the Ca~V~1.3 α1 subunit---but not the Ca~V~1.2 α1 subunit---was significantly increased in the IC 24 hours after alcohol withdrawal. A significant increase in Ca~V~1.3 α1 subunit proteins was also observed 24 hours following alcohol withdrawal, as compared to the 3-hour group. These findings suggest that upregulation of Ca~V~1.3 L-type Ca^2+^ channels might play an important role in the pathogenesis of AWS.

In the brain, Ca~V~1 channels are located primarily in the dendrites and cell bodies; 80% and 20% of these channels are Ca~V~1.2 and Ca~V~1.3 channels, respectively ([@CIT0013]). This predominance of Ca~V~1.2 channels may also occur in the IC. Evidence suggests that Ca~V~1.3 channels activate at more negative voltages and inactivate more slowly than Ca~V~1.2 channels ([@CIT0018]; [@CIT0035]). Given their biophysical properties, Ca~V~1.3 channels may play an important role in the control of Ca^2+^-dependent firing, and these channels can help maintain the Ca^2+^ influx at membrane potentials at which Ca~V~1.2 channels would remain closed. Here, we found that increased susceptibility to AWS was accompanied by an increase in Ca~V~1.3 channels in the IC, consistent with a role for Ca~V~1.3 channels in mediating neuronal hyperexcitability, leading to seizures. Analysis of the ratio of Ca~V~1.3 to Ca~V~1.2 channels reveals that alcohol withdrawal preferentially upregulates Ca~V~1.3 channels (at 24 but not 3 hours during alcohol withdrawal when the susceptibility to seizures peaked) in IC neurons, consistent with the role of these channels in the pathogenesis of AWSs.

During alcohol withdrawal, the IC plays an important role in initiating AGSs ([@CIT0011]; [@CIT0032]; [@CIT0008]; [@CIT0002]). Pharmacological studies found that blocking Ca~V~1 channels during alcohol withdrawal suppresses AGSs, leading to the hypothesis that these channels undergo remodeling, at least in IC neurons ([@CIT0019]). Consistent with this hypothesis, we previously reported increased currents through Ca~V~1 channels in IC neurons during alcohol withdrawal at the time point at which susceptibility to seizures peaks ([@CIT0025]). These findings suggest a possible causal relationship between changes in the composition of Ca~V~1 channels in IC neurons and the occurrence of AWS. Here, we present evidence that the increase in Ca~V~1 channels in IC neurons might not be a consequence of AWS, as Ca~V~1.3 α1 mRNA and protein levels increased in parallel with the occurrence of AWS. Thus, altered Ca~V~1.3 channel expression may predispose the animals to develop AWS.

Alcohol withdrawal--induced clonus (i.e. bouncing generalized clonic-tonic seizures) originate primarily in the brainstem ([@CIT0002]). Whether the changes in Ca~V~1.3 α1 channels that we observed in the IC also occur in other epileptogenic sites in the forebrain (for example, in the hippocampus) is currently unknown. Increased levels of Ca~V~1.3 α1 subunits have been found in cortical neurons during alcohol withdrawal and are associated with increased seizure susceptibility ([@CIT0017]). Similarly, Ca~V~1 channels are upregulated throughout the brain following alcohol withdrawal, and this upregulation occurs in parallel with the occurrence of seizures ([@CIT0036]). Generalized tonic-clonic seizures during alcohol withdrawal resemble seizures observed in the genetically epilepsy-prone rat ([@CIT0002]; [@CIT0006]). In these rats, Ca~V~1.3---but not Ca~V~1.2---α1 subunits were increased in IC neurons of both seizure-naive and seizure-experienced animals ([@CIT0029]). These findings suggest that the upregulation of Ca~V~1.3 channels in IC neurons may be the molecular correlate of the enhanced susceptibility to generalized tonic-clonic seizures originating in the brainstem. In a Mongolian gerbil model of generalized tonic-clonic seizures, no changes in Ca~V~1.3 or Ca~V~1.2 α1 subunits were found in pyramidal cells in the CA1 or dentate gyrus of seizure-prone animals ([@CIT0015]). However, in the CA2 and CA3 regions of the hippocampus, both Ca~V~1.3 and Ca~V~1.2 α1 subunits were significantly increased in pyramidal cells during the pre-seizure state, as well as postictally in seizure-sensitive gerbils ([@CIT0015]). Whether these changes also occur in the brainstem is currently unknown. The increase in both Ca~V~1.3 and Ca~V~1.2 channels in the hippocampus may represent the molecular correlates of increased Ca^2+^-dependent excitability in an inherited model of generalized tonic-clonic seizures. Nevertheless, upregulation of Ca~V~1.3 channels was reported in cerebellar Purkinje cells of seizure-sensitive gerbils ([@CIT0030]). In a kindling model of epileptogenesis, the mRNA level of Ca~V~1.3---but not Ca~V~1.2---channels was increased in the hippocampus during the non-convulsive limbic phase ([@CIT0014]). In contrast, no change in Ca~V~1.3 mRNA levels was found in the hippocampus during generalized seizures ([@CIT0014]). Altered levels of Ca~V~1 channels have also been reported in the thalamus. Notably, significant increases in the mRNA and protein levels of the Ca~V~1.3 α1 subunit were found in the dorsal part of the lateral geniculate nucleus of epileptic Wistar Albino Glaxo from Rijswijk rats; this brain section is a thalamic nucleus that is relevant in the pathophysiology of absence epilepsy ([@CIT0016]; [@CIT0003]; [@CIT0021]). Evidence suggests that altered Ca~V~1.2 channels in hippocampal pyramidal cells may play a role in the pathogenesis of generalized tonic-clonic seizures in a model of febrile seizures ([@CIT0031]). Finally, we posit that upregulation of both Ca~V~1.3 and Ca~V~1.2 channels in the forebrain is associated primarily with non-convulsive seizures, whereas upregulation of Ca~V~1.3 channels in the brainstem and cortex is associated with increased susceptibility to generalized tonic-clonic seizures.

Although we did not specifically examine the mechanism underlying the upregulation of Ca~V~1 channels in the IC following alcohol withdrawal, the consequence of this upregulation is likely an increase in Ca^2+^ influx. Alcohol exposure can suppress the activity of Ca^2+^ channels in IC neurons (N'Gouemo, unpublished observations). Thus, an increase in the number of Ca~V~1 channels following alcohol withdrawal might represent a compensatory mechanism for changes in the activity of IC neuronal circuits in response to decreased Ca~V~1 channel activity during alcohol exposure. Among a myriad of other key functions, Ca~V~1 channels control neuronal excitability, in part via their coupling with Ca^2+^-dependent K^+^ (K~Ca~) channels ([@CIT0024]). Notably, Ca^2+^ influx via Ca~V~1.3 channels can induce a slow afterhyperpolarization by activating K~Ca~ channels, which in turn control neuronal firing ([@CIT0033]; [@CIT0001]; [@CIT0012]). Our finding of Ca~V~1.3 channel upregulation suggests a role for currents that drive a slow afterhyperpolarization. However, both the abundance and current density of the large-conductance K~Ca~ channels that contribute to the slow afterhyperpolarization are decreased in IC neurons following alcohol withdrawal ([@CIT0026]). Thus, the combination of Ca~V~1.3 channel upregulation and large-conductance K~Ca~ channel downregulation might contribute to IC neuronal hyperexcitability and increase seizure susceptibility during alcohol withdrawal.

Our study has some limitations that bear mentioning. Notably, the relatively small sample size used in this study could, in principle, favor type II errors (i.e. a false negative result) over type I errors (i.e. a false positive result). For example, our finding that Ca~V~1.3 α1 subunits are not upregulated 3 hours after ethanol withdrawal may have been due to a type II error. We also found a lack of positive correlation between the expression of *Cacna1d* mRNA and the levels of Ca~V~1.3 α1 subunit proteins, which could be due to different mRNA and protein degradation rates. In the present study, total (cell suface and intracellular) expression of Ca~V~1 protein was measured in IC neurons, which doesn't represent the functional (at the cell surface) Ca~V~1 channels.

In summary, alcohol withdrawal differentially affects the expression of Ca~V~1 channel subtypes in the rat IC neurons. The transient increase in the expression of Ca~V~1.3 channels occurred in parallel with the occurrence of AWSs, whereas the increase in Ca~V~1.2 channels outlasted the enhanced susceptibility to seizures. These findings suggest that Ca~V~1.3 channels in IC neurons play an important role in the pathogenesis of AWSs.
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